Inhibition of janus kinase ۲ by compound AG۴۹۰ suppresses the proliferation of MDA-MB-۲۳۱ cells via up-regulating SARI (suppressor of AP-۱, regulated by IFN)
Publish place: Iranian Journal of Basic Medical Sciences، Vol: 18، Issue: 6
Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 193
This Paper With 5 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-18-6_011
تاریخ نمایه سازی: 3 آبان 1400
Abstract:
Objective(s): The Janus kinase-signal transducers and activators of transcription signaling pathway (JAK/STAT pathway) play an important role in proliferation of breast cancer cells. Previous data showed that inhibition of STAT۳ suppresses the growth of breast cancer cells, but the associated mechanisms are not well understood. This study aims to investigate the effect and associated mechanisms of JAK/STAT pathway inhibitor AG۴۹۰ on proliferation and suppression of breast cancer cells. Materials and Methods: CCK-۸ assay and trypan blue exclusion assay were used to investigate the cytotoxicity of AG۴۹۰ to MDA-MB-۲۳۱ cells. Real-time PCR was used to detect the mRNA level of SARI (suppressor of AP-۱, regulated by IFN). Western blot was used to analyze the protein levels of SARI, phospho-STAT۳ and total STAT۳. Luciferase reporter assay was adopted to explore the mechanism of SARI mRNA upregulation. Results: AG۴۹۰ suppressed the proliferation of MDA-MB-۲۳۱ cells in a dose-dependent manner. AG۴۹۰ significantly up-regulated the mRNA and protein levels of SARI in MDA-MB-۲۳۱ cells. Knockdown of SARI obviously attenuated AG۴۹۰-induced growth suppression effect in MDA-MB-۲۳۱ cells. Furthermore, AG۴۹۰ dramatically enhanced the transcription activity of SARI promoter. But the transcription activity of truncated SARI promoter, which does not contain STAT۳ binding site, cannot be activated by AG۴۹۰ treatment. Conclusion: We demonstrate in this study that AG۴۹۰ suppresses the proliferation of MDA-MB-۲۳۱ cells through transcriptional activation of SARI.
Keywords:
Authors
Yan-xia Zhang
Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, Shandong, China
Li Yan
Department of Radiation Oncology, Linyi People’s Hospital, Linyi, Shandong, China
Guang-yu Liu
Department of Traumatology, Linyi People’s Hospital, Linyi, Shandong, China
Wen-jun Chen
Department of Radiation Oncology, Linyi People’s Hospital, Linyi, Shandong, China
Wei-hong Gong
Department of Radiation Oncology, Linyi People’s Hospital, Linyi, Shandong, China
Jin-ming Yu
Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, Shandong, China
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :